Evidence map›Paper›PMID 37928279›Full record

ArticleIJU case reports2023

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen-Positron Emission Tomography era.

Nikhile Mookerji, Rohan Mittal, Amaris Hui, Tyler Pfanner, Stacey Broomfield, Luke Dean, Benjamin Adam, Christopher Fung, Alexander Tamm, Adam Kinnaird

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nikhile MookerjiDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta Canada.ORCID https://orcid.org/0000-0003-1785-9316
Rohan MittalDepartment of Pathology University of Alberta Edmonton Alberta Canada.
Amaris HuiDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta Canada.
Tyler PfannerDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta Canada.
Stacey BroomfieldDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta Canada.
Luke DeanDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta Canada.
Benjamin AdamDepartment of Pathology University of Alberta Edmonton Alberta Canada.
Christopher FungDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta Canada.
Alexander TammDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta Canada.
Adam KinnairdDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta Canada.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The absence of prostate cancer on final surgical pathology after biopsy-proven prostate cancer is a rare finding. Case presentation: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound-guided biopsy in a man who underwent both magnetic resonance imaging and Conclusion: pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.

Indexed as

multiparametric MRIprostate cancerPSMA PETvanishing cancer

Identifiers

PMID37928279
PMCPMC10622191
OpenAlexW4385781421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.